Blood Vessels, Thrombosis & Hemostasis
Elsevier Β· United States
Aims & Scope⦠Inferred from recent articles
This journal publishes research on blood disorders, including immune thrombotic thrombocytopenic purpura (iTTP), hereditary thrombotic thrombocytopenic purpura (hTTP), and heparin-induced thrombocytopenia (HIT). It also covers vascular anomalies, platelet function, thrombosis, hemostasis, and the development of diagnostic and therapeutic strategies for these conditions.
AI-summarised from recent articles Β· verify on publisher page β
General Information
Submission Info
Ethics & Quality
Think.Check.Submit Compliance
Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.
SJR Quartile by Discipline
Scimago ranks this journal separately in each subject category β its quartile can differ by discipline.
Subject Classification
Research Topics (OpenAlex)
Frequently asked questions about Blood Vessels, Thrombosis & Hemostasis
Is Blood Vessels, Thrombosis & Hemostasis a predatory journal?
PubScope has no integrity flags on record for Blood Vessels, Thrombosis & Hemostasis: it is indexed in Scopus, DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 78/100. Indexing is a transparency signal, not a guarantee β always confirm fit and policies before submitting.
What is the impact factor of Blood Vessels, Thrombosis & Hemostasis?
Blood Vessels, Thrombosis & Hemostasis is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor. Its SCImago SJR score is 0.518.
Is Blood Vessels, Thrombosis & Hemostasis indexed in Scopus and Web of Science?
Blood Vessels, Thrombosis & Hemostasis is indexed in Scopus, DOAJ.
How much does it cost to publish in Blood Vessels, Thrombosis & Hemostasis?
Blood Vessels, Thrombosis & Hemostasis charges an article processing charge (APC) of about $3,000 for open-access publication.
You May Also Like
See all βData updated: 2026-05-26 Β· Sources: SJR, DOAJ, OpenAlex, WoS, Crossref